Back to results
US 11,229,630 B2Granted
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
AssigneeOlema Pharmaceuticals, Inc.
InventorsDavid C. Myles, Peter J. Kushner, Cyrus L. Harmon
Life of this patent
Estimating the term…
Abstract
The present disclosure provides tetrahydro-1H-pyrido[3,4-b]indole compounds or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, rotamer, N-oxide and/or substituted derivative or, optionally in a pharmaceutical composition, for the modulation of disorders mediated by estrogen, or other disorders as more fully described herein.
Claims19
A method of preventing recurrence of a cancer in a patient comprising administering to the patient a compound of Formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein X is —CH2—or —O—;
- Y is
- R1 and R2 are each hydrogen;
- R3 and R4 are each independently selected from hydrogen and halo, and when one of R3 or R4 is halo, the other of R3 or R4 is hydrogen;
- R5 is hydrogen, C1-C6alkyl, C1-C6haloalkyl, C2-C6alkenyl, C0-C4(C3-C6cycloalkyl) or C1-C6heteroalkyl;
- R6 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl or C0-C4(C3-C6cycloalkyl);
- and
- R7 and R8 are each independently selected from hydrogen or C1-C6alkyl.
6 more elements
Dependencies are inferred from the claim text.